Title: "Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia"

PI: Damián García Olmo.

Starting year: 2020

Nº Eudra CT: 2018-002653-29

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz.

Phase: Phase II  

 

Title: "Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A"

PI: Juan A. Bueren, Rocket Pharmaceuticals Inc.

Starting year: 2019

Nº Eudra CT: 2018-002502-31

Sponsor: Rocket Pharmaceuticals Inc.

Phase: Phase II  

 

Title: "A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I"

PI: Juan A. Bueren, Rocket Pharmaceuticals Inc.

Starting year: 2019

Nº Eudra CT: 2018-002680-26

Sponsor: Rocket Pharmaceuticals Inc.

Phase: Phase I/II  

 

Title: "Gene Therapy for Pyruvate Kinase Deficiency (PKD)"

PI: José Carlos Segovia, Rocket Pharmaceuticals Inc.

Starting year: 2020

Nº Eudra CT: 2019-001656-19

Sponsor: Rocket Pharmaceuticals Inc.

Phase: Phase I

 

Title: "Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A (FANCOLEN-1)"

PI: Juan A. Bueren, Julián Sevilla

Starting year: 2016; End year: 2020

Nº Eudra CT: 2011-006100-12 

Sponsor: Hospital infantil Universitario del Niño Jesús (Madrid)

Phase: Phase I/II  

 

Title"Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1"

PI: Juan A. Bueren, Cristina Díaz de Heredia

Starting year: 2013; End year: 2018

Nº Eudra CT: 2011-006197-88 

Sponsor: Hospital Universitari Vall d'Hebron Research Institute

Phase: Phase II

 

Title: "Phase Ib/IIa, escalating dose, single-blind, clinical trial to assess the safety of the intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells (eASCs) to refractory rheumatoid arthritis (RA) patients"

PI: Marina Inmaculada Garín Ferreira

Starting year: 2012; End year: 2019

Nº Eudra CT: 2010-021602-37 

Sponsor: TiGenix, S.A.U.

Phase: Phase Ib/IIa

 

Title: "Trasplante alogénico de progenitores hematopoyéticos con administración de linfocitos T que expresan genes suicidas para el tratamiento de la enfermedad infjerto conntra huésped"

PI: Juan A. Bueren

Starting year: 2006; End year: 2008

Nº EudraCT: 2004-002046-36

Sponsor: Instituto de Salud Carlos III. Fondo de Investigación Sanitaria

Phase: Phase II